VDM spoke with George Adams, MD, MHS, at the 43rd Annual VEITH Symposium regarding the ongoing DANCE and LIMBO trials. | Read More

An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients. | Read More

Johannes Lammer, MD, is professor of radiology and interventional radiology at the Medical University of Vienna in Vienna, Austria. Dr. Lammer is principal investigator for the ESPRIT I trial, which evaluated the safety and performance of the ESPRIT… | Read More

At VEITH Symposium, Dr. Ansel shared new findings from subanalyses as well as 5-year results that show widening benefits from the drug-eluting stent. | Read More

The FDA recently approved a new, more concentrated format of the high-dose bolus of the GP IIb/IIIa agent tirofiban (premixed, ready to use, at 250 mcg/mL in a 15 mL vial). Craig Walker, MD, answers questions about the use of GP IIb/IIIa agents in… | Read More

The 1-year results from IN.PACT Global confirm safety and effectiveness of the In.Pact Admiral DCB in femoropopliteal lesions. Michael R. Jaff, DO, answers questions about the results and their implications for peripheral vascular therapy. | Read More

New technologies are forthcoming in venous disease, and there is a growing interest in venous therapy among operators previously focusing on only arterial disease. Venous disease specialist Seshadri Raju, MD, described the changes that need to occur… | Read More

Ghassan S. Kassab, PhD, an engineer who developed a sizing device for interventional procedures, champions collaboration among physicians, scientists, and engineers to create the most effective medical devices. | Read More

William Lombardi, MD, describes a treatment algorithm developed by himself and his colleagues to treat coronary chronic total occlusions and discusses how this algorithm could translate to peripheral vascular therapy. | Read More

Dheeraj K. Rajan, MD, FRCPC, FSIR, discusses 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (RESCUE) study. | Read More